Eventide Asset Management - Q2 2022 holdings

$4.68 Billion is the total value of Eventide Asset Management's 136 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 23.5% .

 Value Shares↓ Weighting
BHVN SellBIOHAVEN PHARMACTL HLDG CO L$164,521,000
-15.1%
1,129,100
-30.9%
3.52%
+15.8%
MTD SellMETTLER TOLEDO INTERNATIONAL$140,724,000
-19.0%
122,500
-3.2%
3.01%
+10.6%
ARGX SellARGENX SEsponsored adr$121,014,000
-7.0%
319,400
-22.6%
2.59%
+27.0%
ODFL  OLD DOMINION FREIGHT LINE IN$114,096,000
-14.2%
445,2000.0%2.44%
+17.1%
FIVN SellFIVE9 INC$113,724,000
-18.2%
1,247,800
-0.9%
2.43%
+11.6%
ASND SellASCENDIS PHARMA A/Ssponsored adr$111,459,000
-28.6%
1,199,000
-9.8%
2.38%
-2.5%
PANW BuyPALO ALTO NETWORKS INC$109,969,000
-12.2%
222,637
+10.6%
2.35%
+19.8%
CTAS SellCINTAS CORP$105,746,000
-14.2%
283,100
-2.2%
2.26%
+17.2%
CRWD BuyCROWDSTRIKE HLDGS INCcl a$102,501,000
-25.5%
608,100
+0.3%
2.19%
+1.6%
WCN  WASTE CONNECTIONS INC$99,664,000
-11.3%
804,0000.0%2.13%
+21.1%
NEP SellNEXTERA ENERGY PARTNERS LP$96,158,000
-30.7%
1,296,627
-22.1%
2.06%
-5.4%
TT SellTRANE TECHNOLOGIES PLC$94,026,000
-17.0%
724,000
-2.4%
2.01%
+13.3%
ROP SellROPER TECHNOLOGIES INC$93,414,000
-36.7%
236,700
-24.2%
2.00%
-13.5%
RXDX  PROMETHEUS BIOSCIENCES INC$91,259,000
-25.2%
3,232,7000.0%1.95%
+2.0%
IDXX SellIDEXX LABS INC$90,243,000
-41.4%
257,300
-8.7%
1.93%
-20.1%
DLO SellDLOCAL LTD$89,655,000
-23.9%
3,415,443
-9.4%
1.92%
+3.8%
POOL  POOL CORP$86,789,000
-16.9%
247,1000.0%1.86%
+13.4%
ZI BuyZOOMINFO TECHNOLOGIES INC$83,945,000
-32.3%
2,525,419
+21.6%
1.80%
-7.6%
KRTX SellKARUNA THERAPEUTICS INC$78,360,000
-17.4%
619,400
-17.2%
1.68%
+12.8%
TTD SellTHE TRADE DESK INC$76,520,000
-45.8%
1,826,685
-10.4%
1.64%
-26.0%
LOW SellLOWES COS INC$76,436,000
-14.3%
437,600
-0.7%
1.64%
+17.0%
GH BuyGUARDANT HEALTH INC$67,812,000
-22.0%
1,681,000
+28.0%
1.45%
+6.4%
KNBE BuyKNOWBE4 INCcl a$65,799,000
-32.1%
4,212,483
+0.0%
1.41%
-7.4%
HUBS SellHUBSPOT INC$65,161,000
-37.3%
216,733
-0.9%
1.39%
-14.4%
APTV  APTIV PLC$64,104,000
-25.6%
719,7000.0%1.37%
+1.6%
ENTG SellENTEGRIS INC$59,574,000
-45.1%
646,630
-21.8%
1.27%
-25.1%
CCI BuyCROWN CASTLE INTL CORP NEW$58,849,000
-4.3%
349,500
+4.9%
1.26%
+30.6%
SPT SellSPROUT SOCIAL INC$57,544,000
-31.6%
990,943
-5.6%
1.23%
-6.6%
GNRC SellGENERAC HLDGS INC$56,793,000
-48.7%
269,700
-27.5%
1.22%
-29.9%
LNG BuyCHENIERE ENERGY INC$54,183,000
+33.6%
407,300
+39.3%
1.16%
+82.5%
TREX  TREX CO INC$53,876,000
-16.7%
990,0000.0%1.15%
+13.7%
EXAS SellEXACT SCIENCES CORP$53,791,000
-48.4%
1,365,600
-8.3%
1.15%
-29.5%
DOCS NewDOXIMITY INCcl a$52,669,0001,512,602
+100.0%
1.13%
DHI SellD R HORTON INC$51,727,000
-34.6%
781,500
-26.4%
1.11%
-10.7%
LRCX SellLAM RESEARCH CORP$48,368,000
-50.1%
113,500
-37.1%
1.03%
-31.9%
DDOG BuyDATADOG INC$48,250,000
-35.6%
506,619
+2.3%
1.03%
-12.2%
XMTR BuyXOMETRY INC$47,643,000
+8.0%
1,404,164
+17.0%
1.02%
+47.5%
GLBE SellGLOBAL E ONLINE LTD$47,467,000
-43.7%
2,353,371
-5.7%
1.02%
-23.2%
COLL  COLLEGIUM PHARMACEUTICAL INC$46,596,000
-13.0%
2,629,5930.0%1.00%
+18.8%
COGT BuyCOGENT BIOSCIENCES INC$45,957,000
+57.3%
5,095,000
+30.6%
0.98%
+114.6%
MPWR  MONOLITHIC PWR SYS INC$45,258,000
-20.9%
117,8480.0%0.97%
+7.9%
BEP  BROOKFIELD RENEWABLE PARTNERpartnership unit$43,013,000
-15.3%
1,236,0000.0%0.92%
+15.7%
A SellAGILENT TECHNOLOGIES INC$42,543,000
-21.7%
358,200
-12.7%
0.91%
+6.9%
CLDX  CELLDEX THERAPEUTICS INC NEW$38,976,000
-20.8%
1,445,7000.0%0.83%
+8.0%
COUR BuyCOURSERA INC$37,422,000
-34.7%
2,639,093
+6.0%
0.80%
-11.0%
NOVT  NOVANTA INC$33,956,000
-14.8%
280,0000.0%0.73%
+16.3%
TSM  TAIWAN SEMICONDUCTOR MFG LTDsponsored ads$33,518,000
-21.6%
410,0000.0%0.72%
+7.0%
BuyDUOLINGO INC$33,127,000
+35.3%
378,375
+46.9%
0.71%
+84.4%
ASML SellASML HOLDING N V$32,836,000
-52.1%
69,000
-32.7%
0.70%
-34.6%
KURA SellKURA ONCOLOGY INC$32,813,000
-1.0%
1,790,144
-13.1%
0.70%
+35.3%
ENPH BuyENPHASE ENERGY INC$31,824,000
+9.5%
163,000
+13.1%
0.68%
+49.7%
LSCC BuyLATTICE SEMICONDUCTOR CORP$31,551,000
+9.7%
650,544
+37.9%
0.68%
+49.7%
HASI SellHANNON ARMSTRONG SUST INFR C$31,146,000
-27.9%
822,664
-9.6%
0.67%
-1.6%
MASS Buy908 DEVICES INC$30,846,000
+15.1%
1,498,101
+6.2%
0.66%
+57.1%
CWEN SellCLEARWAY ENERGY INCcl c$29,349,000
-47.5%
842,400
-44.9%
0.63%
-28.2%
REXR SellREXFORD INDL RLTY INC$28,869,000
-35.2%
501,293
-16.0%
0.62%
-11.6%
ZYME  ZYMEWORKS INC$28,515,000
-19.1%
5,380,2000.0%0.61%
+10.5%
ZNTL BuyZENTALIS PHARMACEUTICALS INC$28,212,000
-19.7%
1,004,000
+31.9%
0.60%
+9.6%
BEPC  BROOKFIELD RENEWABLE CORPcl a sub vtg$27,598,000
-18.7%
775,0190.0%0.59%
+10.9%
VRSK SellVERISK ANALYTICS INC$27,314,000
-22.9%
157,800
-4.4%
0.58%
+5.2%
NVT SellNVENT ELECTRIC PLC$26,919,000
-12.3%
859,200
-2.7%
0.58%
+19.8%
STE  STERIS PLC$23,127,000
-14.7%
112,1850.0%0.50%
+16.5%
NBIX  NEUROCRINE BIOSCIENCES INC$22,908,000
+4.0%
235,0000.0%0.49%
+42.0%
WMB BuyWILLIAMS COS INC$22,399,000
+2.5%
717,700
+9.7%
0.48%
+40.1%
MDB SellMONGODB INCcl a$22,317,000
-43.7%
86,000
-3.8%
0.48%
-23.2%
BPMC SellBLUEPRINT MEDICINES CORP$22,149,000
-41.5%
438,500
-26.0%
0.47%
-20.1%
IMVT  IMMUNOVANT INC$20,953,000
-29.2%
5,372,5120.0%0.45%
-3.4%
SellDICE THERAPEUTICS INC$20,778,000
-41.0%
1,370,261
-26.8%
0.44%
-19.6%
CMS NewCMS ENERGY CORP$19,359,000286,800
+100.0%
0.41%
RGEN  REPLIGEN CORP$19,326,000
-13.7%
119,0000.0%0.41%
+17.7%
WEC BuyWEC ENERGY GROUP INC$19,323,000
+33.2%
192,000
+32.0%
0.41%
+81.9%
NDAQ SellNASDAQ INC$18,290,000
-17.2%
119,900
-3.3%
0.39%
+13.0%
FRC BuyFIRST REP BK SAN FRANCISCO C$18,227,000
+3.7%
126,400
+16.6%
0.39%
+41.8%
CCXI  CHEMOCENTRYX INC$18,049,000
-1.2%
728,3850.0%0.39%
+35.0%
ESI  ELEMENT SOLUTIONS INC$17,284,000
-18.7%
971,0000.0%0.37%
+11.1%
SNPS SellSYNOPSYS INC$17,055,000
-30.0%
56,157
-23.1%
0.36%
-4.2%
PNR  PENTAIR PLC$16,038,000
-15.6%
350,4000.0%0.34%
+15.1%
YETI  YETI HLDGS INC$15,967,000
-27.9%
369,0000.0%0.34%
-1.7%
CGNX  COGNEX CORP$15,265,000
-44.9%
359,0000.0%0.33%
-24.9%
ISRG  INTUITIVE SURGICAL INC$15,053,000
-33.5%
75,0000.0%0.32%
-9.3%
ADCT SellADC THERAPEUTICS SA$14,946,000
-48.5%
1,879,959
-4.8%
0.32%
-29.7%
NRIX SellNURIX THERAPEUTICS INC$14,621,000
-44.2%
1,154,000
-38.3%
0.31%
-23.7%
BCYC SellBICYCLE THERAPEUTICS PLCsponsored ads$14,327,000
-74.2%
853,800
-32.4%
0.31%
-64.8%
XENE NewXENON PHARMACEUTICALS INC$14,288,000469,700
+100.0%
0.31%
STRO  SUTRO BIOPHARMA INC$14,114,000
-36.6%
2,708,9750.0%0.30%
-13.5%
KLAC SellKLA CORP$14,048,000
-43.1%
44,028
-34.7%
0.30%
-22.5%
SYY  SYSCO CORP$13,664,000
+3.8%
161,2980.0%0.29%
+41.7%
ANNX  ANNEXON INC$13,672,000
+38.1%
3,626,5080.0%0.29%
+88.4%
AESC  AES CORPunit 99/99/9999$13,044,000
-12.7%
151,1000.0%0.28%
+19.2%
CDW NewCDW CORP$13,014,00082,600
+100.0%
0.28%
BAX NewBAXTER INTL INC$12,756,000198,600
+100.0%
0.27%
VECT  VECTIVBIO HLDG AG$12,631,000
+14.9%
2,339,0440.0%0.27%
+57.0%
ELS SellEQUITY LIFESTYLE PPTYS INC$11,388,000
-34.8%
161,600
-29.2%
0.24%
-10.6%
ICPT  INTERCEPT PHARMACEUTICALS IN$11,048,000
-15.1%
800,0000.0%0.24%
+15.7%
EPIX SellESSA PHARMA INC$10,602,000
-58.9%
3,365,568
-19.3%
0.23%
-43.8%
IEX  IDEX CORP$10,607,000
-5.3%
58,4000.0%0.23%
+29.7%
SHLS  SHOALS TECHNOLOGIES GROUP INcl a$10,231,000
-3.3%
620,8320.0%0.22%
+31.9%
APTVPRA NewAPTIV PLC5.5% cnv pfd a$10,012,00094,500
+100.0%
0.21%
PHVS BuyPHARVARIS N V$9,951,000
+75.8%
450,251
+48.8%
0.21%
+139.3%
 GXO LOGISTICS INCORPORATED$9,519,000
-39.4%
220,0000.0%0.20%
-17.1%
WD SellWALKER & DUNLOP INC$9,108,000
-42.3%
94,535
-22.5%
0.20%
-21.1%
PRAX SellPRAXIS PRECISION MEDICINES I$8,619,000
-80.8%
3,518,062
-20.0%
0.18%
-73.8%
VCYT  VERACYTE INC$8,318,000
-27.8%
418,0000.0%0.18%
-1.7%
VITL SellVITAL FARMS INC$8,313,000
-69.3%
950,092
-56.6%
0.18%
-58.0%
PRVA NewPRIVIA HEALTH GROUP INC$8,090,000277,800
+100.0%
0.17%
EGP  EASTGROUP PPTYS INC$7,840,000
-24.1%
50,8000.0%0.17%
+3.7%
MRTX SellMIRATI THERAPEUTICS INC$7,586,000
-79.7%
113,000
-75.1%
0.16%
-72.3%
TALS  TALARIS THERAPEUTICS INC$7,041,000
-54.2%
1,561,0920.0%0.15%
-37.3%
 ROIVANT SCIENCES LTD$6,738,000
-17.6%
1,690,3000.0%0.14%
+12.5%
EVH NewEVOLENT HEALTH INCcl a$6,655,000216,700
+100.0%
0.14%
TRGP SellTARGA RES CORP$6,326,000
-42.9%
106,022
-27.7%
0.14%
-22.0%
OPCH NewOPTION CARE HEALTH INC$6,155,000221,500
+100.0%
0.13%
PLD SellPROLOGIS INC.$5,825,000
-78.4%
49,513
-70.4%
0.12%
-70.4%
ARE BuyALEXANDRIA REAL ESTATE EQ IN$5,787,000
-14.7%
39,900
+18.4%
0.12%
+17.0%
HZNP NewHORIZON THERAPEUTICS PUB L$5,567,00069,800
+100.0%
0.12%
XPO  XPO LOGISTICS INC$5,538,000
-33.9%
115,0000.0%0.12%
-9.9%
GRMN SellGARMIN LTD$5,473,000
-24.4%
55,700
-8.7%
0.12%
+3.5%
FRLN BuyFREELINE THERAPEUTICS HLDGSsponsored ads$5,168,000
+30.2%
5,950,000
+65.0%
0.11%
+79.0%
SNV SellSYNOVUS FINL CORP$5,123,000
-70.1%
142,100
-59.3%
0.11%
-59.0%
LOB  LIVE OAK BANCSHARES INC$4,642,000
-33.4%
136,9830.0%0.10%
-9.2%
SWAV NewSHOCKWAVE MED INC$4,512,00023,600
+100.0%
0.10%
NARI NewINARI MED INC$4,195,00061,700
+100.0%
0.09%
SHW  SHERWIN WILLIAMS CO$4,142,000
-10.3%
18,5000.0%0.09%
+23.6%
INSP NewINSPIRE MED SYS INC$4,183,00022,900
+100.0%
0.09%
IONS NewIONIS PHARMACEUTICALS INC$4,072,000110,000
+100.0%
0.09%
DSGN SellDESIGN THERAPEUTICS INC$3,942,000
-39.0%
281,569
-29.6%
0.08%
-16.8%
WMS SellADVANCED DRAIN SYS INC DEL$3,607,000
-47.7%
40,052
-31.0%
0.08%
-28.7%
IRTC NewIRHYTHM TECHNOLOGIES INC$3,165,00029,300
+100.0%
0.07%
PHAT  PHATHOM PHARMACEUTICALS INC$2,838,000
-38.0%
336,2230.0%0.06%
-15.3%
SLAB  SILICON LABORATORIES INC$2,683,000
-6.6%
19,1370.0%0.06%
+26.7%
FLYW NewFLYWIRE CORPORATION$2,343,000132,921
+100.0%
0.05%
MNDY SellMONDAY COM LTD$2,105,000
-59.0%
20,409
-37.2%
0.04%
-43.8%
 GUARDANT HEALTH INCnote 11/1$1,805,000
-22.9%
2,900,0000.0%0.04%
+5.4%
CIEN SellCIENA CORP$1,462,000
-43.9%
32,000
-25.6%
0.03%
-24.4%
BuyARTERIS INC$1,384,000
-45.1%
198,509
+2.3%
0.03%
-25.0%
KBH SellKB HOME$999,000
-78.2%
35,100
-75.2%
0.02%
-70.8%
ETTX ExitENTASIS THERAPEUTICS HLDGS I$0-590,602
-100.0%
-0.02%
BOLT ExitBOLT BIOTHERAPEUTICS INC$0-859,826
-100.0%
-0.04%
BRKS ExitAZENTA INC$0-29,700
-100.0%
-0.04%
OM ExitOUTSET MED INC$0-69,000
-100.0%
-0.05%
CRDF ExitCARDIFF ONCOLOGY INC$0-1,467,922
-100.0%
-0.06%
FOUR ExitSHIFT4 PMTS INCcl a$0-70,000
-100.0%
-0.07%
ExitENPHASE ENERGY INCnote 3/0$0-4,463,000
-100.0%
-0.07%
IMGN ExitIMMUNOGEN INC$0-1,000,000
-100.0%
-0.08%
APTVPRA ExitAPTIV PLC5.5% cnv pfd a$0-94,500
-100.0%
-0.20%
XNCR ExitXENCOR INC$0-500,755
-100.0%
-0.21%
CGEM ExitCULLINAN ONCOLOGY INC$0-1,440,145
-100.0%
-0.24%
ExitPALO ALTO NETWORKS INCnote 0.750% 7/0$0-6,810,000
-100.0%
-0.25%
ExitNCINO INC$0-416,200
-100.0%
-0.27%
SNDX ExitSYNDAX PHARMACEUTICALS INC$0-1,165,000
-100.0%
-0.32%
SMAR ExitSMARTSHEET INC$0-697,000
-100.0%
-0.60%
DT ExitDYNATRACE INC$0-2,386,741
-100.0%
-1.76%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

About Eventide Asset Management

Eventide Asset Management is a Boston-based investment firm that specializes in providing investment solutions to investors who are looking for long-term growth opportunities. The company was founded in 2008 by a group of experienced investment professionals who shared a common vision of creating a firm that would focus on investing in companies that are making a positive impact on society.

The company's investment philosophy is based on the belief that companies that are making a positive impact on society are more likely to be successful in the long run. Eventide's investment team conducts extensive research to identify companies that are aligned with this philosophy and have the potential to deliver strong returns over the long term.

The company's investment strategies are managed by a team of experienced professionals, including CEO Robin John, COO Finny Kuruvilla, and Chief Investment Officer, Dr. Finny Kuruvilla. The team has a proven track record of delivering strong returns to investors, and their investment strategies have been recognized by industry experts.

Eventide Asset Management offers a range of investment solutions, including mutual funds, separately managed accounts, and exchange-traded funds (ETFs). The company's funds are available to individual investors, financial advisors, and institutional investors.

Overall, Eventide Asset Management is a reputable investment firm that has a strong focus on investing in companies that are making a positive impact on society. The company's experienced investment team and proven track record make it a compelling option for investors who are looking for long-term growth opportunities.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
LOWES COS INC43Q2 20243.2%
PALO ALTO NETWORKS INC43Q2 20243.6%
ASML HOLDINGS NV43Q2 20241.9%
REPLIGEN CORP43Q2 20240.5%
VERACYTE INC41Q2 20241.5%
NEUROCRINE BIOSCIENCES INC40Q3 20231.1%
LAM RESEARCH CORP38Q2 20243.4%
COLLEGIUM PHARMACEUTICAL INC37Q2 20242.6%
BLUEPRINT MEDICINES CORP36Q2 20241.3%
XPO LOGISTICS INC34Q1 20233.8%

View Eventide Asset Management's complete holdings history.

Latest significant ownerships (13-D/G)
Eventide Asset Management Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
908 Devices Inc.February 14, 20241,430,9954.4%
Annexon, Inc.Sold outFebruary 14, 202400.0%
Celldex Therapeutics, Inc.February 14, 20243,630,0136.6%
COLLEGIUM PHARMACEUTICAL, INCFebruary 14, 20242,630,4788.1%
Freeline Therapeutics Holdings plcSold outFebruary 14, 202400.0%
Inozyme Pharma, Inc.February 14, 20243,179,8375.2%
Korro Bio, Inc.February 14, 2024546,3256.8%
MARINUS PHARMACEUTICALS, INC.February 14, 20244,529,9978.3%
Mirum Pharmaceuticals, Inc.February 14, 20242,693,5815.8%
Praxis Precision Medicines, Inc.Sold outFebruary 14, 202400.0%

View Eventide Asset Management's complete significant-ownership history.

Latest filings
TypeFiled
N-PX2024-08-27
13F-HR2024-08-13
SC 13G/A2024-08-09
13F-HR2024-05-15
13F-HR/A2024-02-20
13F-HR2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14
SC 13G/A2024-02-14

View Eventide Asset Management's complete filings history.

Compare quarters

Export Eventide Asset Management's holdings